Previous Section
General Interest Articles
11. Myelodysplastic syndromes: incidence and survival in the United States.
- Author
- Ma X; Does M; Raza A; Mayne ST;
- Institution
- Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520, USA. xiaomei.ma@yale.edu
- Journal
- Cancer. 2007 Apr 15;109(8):1536-42.
- Abstract URL
- Click here to view abstract
12. The incidence and impact of thrombocytopenia in myelodysplastic syndromes.
- Author
- Kantarjian H; Giles F; List A; Lyons R; Sekeres MA; Pierce S; Deuson R; Leveque J;
- Institution
- Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, Texas.
- Journal
- Cancer. 2007 Mar 15;109(9):1705-1714.
- Abstract URL
- Click here to view abstract
13. Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes.
- Author
- Golshayan AR; Jin T; Maciejewski J; Fu AZ; Bershadsky B; Kattan MW; Kalaycio ME; Sekeres MA;
- Institution
- Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA.
- Journal
- Br J Haematol. 2007 Apr;137(2):125-32.
- Abstract URL
- Click here to view abstract
14. The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey.
- Author
- Demirkan F; Alacacioglu I; Piskin O; Ozsan HG; Akinci B; Ozcan AM; Yavuzsen T; Yuksel E; Undar B;
- Institution
- Division of Hematology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey. fatih.demirkan@deu.edu.tr
- Journal
- Leuk Lymphoma. 2007 Jul;48(7):1372-8.
- Abstract URL
- Click here to view abstract
15. Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1).
- Author
- Sevilla J; Fernandez-Plaza S; Lassaletta A; Gonzalez-Vicent M; Contra T; Madero L;
- Institution
- Oncohematologia pediatrica Hospital Nino Jesus, Madrid, Spain. jsevilla.hnjs@salud.madrid.org
- Journal
- J Pediatr Hematol Oncol. 2007 Dec;29(12):839-40.
- Abstract URL
- Click here to view abstract
16. Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.
- Author
- Valent P; Krieger O; Stauder R; Wimazal F; Nosslinger T; Sperr WR; Sill H; Bettelheim P; Pfeilstocker M;
- Institution
- Department of Internal Medicine I, Division of Haematology & Haemostaseology, Medical University of Vienna, Austria. peter.valent@meduniwien.ac.at
- Journal
- Eur J Clin Invest. 2008 Mar;38(3):143-9. Epub 2008 Jan 24.
- Abstract URL
- Click here to view abstract
17. Meeting report: myelodysplastic syndromes at ASH 2007.
- Author
- Itzykson R; Gardin C; Fenaux P;
- Institution
- Service d'hematologie clinique, Hopital Avicenne, Bobigny, France.
- Journal
- Leukemia. 2008 May;22(5):893-7. Epub 2008 Mar 6.
- Abstract URL
- Click here to view abstract
18. Advances in the treatment of myelodysplastic syndromes.
- Author
- Institution
- Journal
- Clin Adv Hematol Oncol. 2008 Mar;6(3 Suppl 6):1-13; discussion 14; quiz 15-6.
- Abstract URL
- Click here to view abstract
19. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.
- Author
- Sloand EM; Wu CO; Greenberg P; Young N; Barrett J;
- Institution
- National Heart, Lung and Blood Institute, Division of Intramural Research, Hematology Branch, Bethesda, MD 20892, USA. sloande@nhlbi.nih.gov
- Journal
- J Clin Oncol. 2008 May 20;26(15):2505-11. Epub 2008 Apr 14.
- Abstract URL
- Click here to view abstract
20. A prognostic score for patients with lower risk myelodysplastic syndrome.
- Author
- Garcia-Manero G; Shan J; Faderl S; Cortes J; Ravandi F; Borthakur G; Wierda WG; Pierce S; Estey E; Liu J; Huang X; Kantarjian H;
- Institution
- Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ggarciam@mdanderson.org
- Journal
- Leukemia. 2008 Mar;22(3):538-43. Epub 2007 Dec 13.
- Abstract URL
- Click here to view abstract
Next: Drug Therapy
